Mitochondrially-mediated toxicity of bile acids

Toxicology

Volumn 203, Issue 1-3, 2004, Pages 1-15

  Palmeira, Carlos M ^a   Rolo, Anabela P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Bile acids; Cholestasis; Mitochondria

Indexed keywords

BILE ACID;

CELL FUNCTION; CHOLESTATIC HEPATITIS; DISEASE COURSE; HUMAN; HYDROPHILICITY; LITERATURE; LIVER CELL DAMAGE; LIVER MITOCHONDRION; LIVER TOXICITY; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY;

EID: 4444311570     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.06.001     Document Type: Review

References (93)

1. Angulo P., Lindor K.D. Management of primary biliary cirrhosis and autoimmune cholangitis. Clin. Liver Dis. 2:1998;333-351
2. Ballatori N., Truong A.T. Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine. Mol. Pharmacol. 38:1990;64-71
3. Baron V., Muriel P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim. Biophys. Acta. 1472:1999;173-180
4. Benz C., Angermuller S., Tox U., Kloters-Plachky P., Riedel H.D., Sauer P., Stremmel W., Stiehl A. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J. Hepatol. 28:1998;99-106
5. Bernstein C., Payne C.M., Bernstein H., Garewal H. Activation of the metallothionein IIA promoter and other key stress response elements by ursodeoxycholate in HepG2 cells: relevance to the cytoprotective function of ursodeoxycholate. Pharmacology. 65:2002;2-9
6. 2+ mechanisms defective in cholestasis. J. Clin. Invest. 92:1993;2984-2993
7. Beuers U., Boyer J.L., Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanisms of avtion and therapeutic applications. Hepatology. 28:1998;1449-1453
8. Billington D., Evans C.E., Godfrey P.P., Coleman R. Effects of bile salts on the plasma membranes of isolated rat hepatocytes. Biochem. J. 188:1980;321-327
9. Botla R., Spivey J.R., Aguilar H., Bronk S.F., Gores G.J. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J. Pharmacol. Exp. Ther. 272:1995;930-938
10. Broekemeier K.M., Dempsey M.E., Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264:1989;7826-7830
11. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science. 294:2001;1866-1870
12. Chen J., Farrel G.C. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J. Gastroenterol. Hepatol. 11:1996;870-877
13. Cheng H.-Y., Randall C.S., Holl W.W., Constantinides P.P., Yue T.-L., Feuerstein G.Z. Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. Biochim. Biophys. Acta. 1284:1996;20-28
14. Cheng Y., Tauschel H.D., Nilsson A., Duan R.D. Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon. Scand. J. Gastroenterol. 34:1999;915-920
15. Combettes L., Dumont M., Berthon B., Erlinger S., Claret M. Release of calcium from the endoplasmic reticulum by bile acids in rat liver cells. J. Biol. Chem. 263:1988;2299-2303
16. Cremesti A., Paris F., Grassme H., Holler N., Tschopp J., Fuks Z., Gulbins E. Ceramide enables Fas to cap and kill. J. Biol. Chem. 276:2001;23954-23961
17. Datta S.R., Ranger A.M., Lin M.Z., Sturgill J.F., Ma Y.C., Cowan C.W., Dikkes P., Korsmeyer S.J., Greenberg M.E. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell. 3:2002;631-643
18. Duan R.D., Nilsson A. Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity. Hepatology. 26:1997;823-830
19. Falany C.N., Johnson M.R., Barnes S., Diasio R.B. Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA: amino acid N-acyltransferase. J. Biol. Chem. 269:1994;19375-19379
20. Fischer S., Beuers U., Spengler U., Zwiebel F.M., Koebe H.-G. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin. Chim. Acta. 2511:1996;173-186
21. +/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology. 110:1996;199-209
22. Gazawi H., Ljubuncic P., Cogan U., Hochgraff E., Ben-Shachar D., Bomzon A. The effects of bile acids on ß-adrenoreceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes. Biochem. Pharmacol. 59:2000;1623-1628
23. George J., Murray M., Byth K., Farrel G.C. Differential alterations of cytochrome P-450 proteins in livers from patients with severe chronic liver disease. Hepatology. 21:1995;120-128
24. Goldfarb S., Singer E.J., popper H. Experimental cholangitis due to alpha-naphthyl-isothiocyanate (ANIT). Am. J. Pathol. 40:1962;685-698
25. Gores G.J., Miyoshi H., Botla R., Aguilar H.I., Bronk S.F. Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a role for mitochondrial proteases. Biochim. Biophys. Acta. 1366:1998;167-175
26. Graf D., Kurz A.K., Reinehr R., Fischer R., Kircheis G., Haussinger D. Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology. 36:2002;829-839
27. Greim H., Czygan P., Schaffner F., Popper H. Determination of bile acids in needle biopsies of human liver. Biochem. Med. 8:1973;280-286
28. Gumpricht E., Devereaux M.W., Dahl R.H., Sokol R.J. Glutathione status of isolated rat hepatocytes affects bile acid-induced cellular necrosis but not apoptosis. Toxicol. Appl. Pharmacol. 164:2000;102-111
29. Hansch C., Dunn W.J. III Linear relationships between lipophilic character and biological activity of drugs. J. Pharmacol. Sci. 61:1972;1-19
30. Higuchi H., Bronk S.F., Takikawa Y., Werneburg N., Takimoto R., El-Deiry W., Gores G.J. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis. J. Biol. Chem. 276:2001;38610-386188
31. Higuchi H., Yoon J.H., Grambihler A., Werneburg N., Bronk S.F., Gores G.J. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J. Biol. Chem. 278:2003;454-461
32. Hillstrom J., Duane W.C., Eckfeldt J.H., Furne J., Levitt M.D. Lack of benefit of ursodeoxycholic acid in drug-induced cholestasis in the rat. Exp. Biol. Med. 200:1992;122-126
33. Hofmann A.F., Mysels K.J. Bile salts as biological surfactants. Colloids Surf. 30:1988;145-173
34. Hofmann, A., 1994. Bile acids. In: Arias, I.M., Boyer, J.L., Fausto, N., Jakoby, W.B., Schacter, D.A., Shafritz, D.A. (Eds.), The Liver: Biology and Pathobiology. Raven Press, New York, pp. 678-710.
35. Hofmann, A.F., Hagey, L.R., 1998. Bile acids and biliary disease: peaceful coexistence versus deadly warfare. In: Blum, H.E., Bode, C., Sartor, R.B. (Eds.), Gut and Liver. Kluwer Academic Publishers, Lancaster, pp. 85-103.
36. Isaacson Y., Van Thiel D.H. Increased membrane fluidity and cholestasis: associated but not linked consequences of estrogen treatment. J. Lab. Clin. Med. 112:1988;663-666
37. Javitt, N.B., 1982. Bile acids and hepatobiliary disease. In: Schiff, L., Schiff, E.R. (Eds.), Diseases of the Liver. Lippincott, Philadelphia, pp. 119-150.
38. Jones B.A., Rao Yi-P., Stravitz T., Gores G.J. Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C. Am. J. Physiol. 272:1997;G1109-G1115
39. Joubert P. Cholic acid and the heart: in vitro studies of the effect on heart rate and myocardial contractility in the rat. Clin. Exp. Pharmacol. Physiol. 5:1978;9-16
40. Kessel D., Caruso J.A., Reiners J.J. Jr. Potentiation of photodynamic therapy by ursodeoxycholic acid. Cancer Res. 60:2000;6985-6988
41. Krähenbühl S., Talos C., Sven F., Reichen J. Toxicity of bile acids on the electron transport chain in isolated rat liver mitochondria. Hepatology. 19:1994a;471-479
42. Krähenbühl S., Fischer S., Talos C., Reichen J. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. Hepatology. 20:1994b;1595-1601
43. Lee J.M., Trauner M., Soroka C.J., Stieger B., Meier P.J., Boyer J.L. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology. 118:2000;163-172
44. Lemonnier F., Cresteil D., Feneant M., Couturier M., Bernard O., Alagille D. Plasma lipid peroxides in cholestatic children. Acta Paediatr. Scand. 76:1987;928-934
45. Lieser M.J., Park J., Natori S., Jones B.A., Bronk S.F., Gores G.J. Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology. 115:1998;693-701
46. Lock S., Lavigne J., Plaa G.L. The effect of alpha-naphthylisothiocyanate on bile secretion prior to and during the onset of cholestasis in the rat. Toxicol. Lett. 10:1982;50-57
47. Martinez-Diez M.C., Serrano M.A., Monte M.J., Marin J.J. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture. Biochim. Biophys. Acta. 1500:2000;153-160
48. Meier P.J., Steger B. Bile salt transporters. Annu. Rev. Physiol. 64:2002;635-661
49. Mitsuyoshi H., Nakashima T., Sumida Y., Yoh T., Nakajima Y., Ishikawa H., Inaba K., Sakamoto Y., Okanoue T., Kashima K. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem. Biophys. Res. Commun. 263:1999;537-542
50. Miyoshi H., Rust C., Roberts P.J., Burgart L.J., Gores G.J. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology. 117:1999;669-677
51. Müller M., Jansen P.L.M. Molecular aspects of hepatobiliary transport. Am. J. Physiol. 272:1997;G1285-G1303
52. Nathanson M.H., Boyer J.L. Mechanisms and regulation of bile secretion. Hepatology. 14:1991;551-566
53. Neuberger J. URSO-panacea or placebo? Hepatology. 31:2000;1027-1028
54. Oh S.H., Yun K.J., Nan J.X., Sohn D.H., Lee B.H. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes. Arch. Toxicol. 77:2003;110-115
55. Oliveira P.J., Esteves T., Rolo A.P., Palmeira C.M., Moreno A.J. Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism. Cardiovasc. Toxicol. 4:2004;11-20
56. Ostrow, J.D., 1993. Metabolism of bile salts in cholestasis. In: Tavoloni, N., Berk, P.D. (Eds.), Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. Raven, New York, pp. 673-712.
57. Oyama K., Shiota G., Murawaki Y., Kawasaki H. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis. 23:2002;885-892
58. Patel T., Bronk S.F., Gores G.J. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J. Clin. Invest. 94:1994;2183-2192
59. Patel T., Gores G.J. Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E. Toxicol. Appl. Pharmacol. 142:1997;116-122
60. Plaa G.L., Priestley B.G. Intrahepatic cholestasis by drugs and chemicals. Pharmacol. Rev. 28:1976;207-273
61. Qiao L., Studer E., Leach K., McKinstry R., Gupta S., Decker R., Kukreja R., Valerie K., Nagarkatti P., El Deiry W., Molkentin J., Schmidt-Ulrich R., Fisher P.B., Grant S., Hylemon P.B., Dent P. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol. Biol. Cell. 12:2001;2609-2645
62. Qiao L., Yacoub A., Studer E., Gupta S., Pei X.Y., Grant S., Hylemon P.B., Dent P. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology. 35:2002;779-789
63. Rodrigues C.M.P., Fan G., Ma X., Kren B.T., Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101:1998;2790-2799
64. Rodrigues C.M., Ma X., Stieers C.L., Fan G., Kren B.T., Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6:1999;842-854
65. Rodrigues C.M., Stieers C.L., Keene C.D., Ma X., Kren B.T., Low W.C., Steer C.J. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. J. Neurochem. 75:2000;2368-2379
66. Rolo A.P., Oliveira P.J., Moreno A.J., Palmeira C.M. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol. Sci. 57:2000;177-185
67. Rolo A.P., Oliveira P.J., Moreno A.J., Palmeira C.M. Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondria. Biosci. Rep. 21:2001a;73-80
68. Rolo A.P., Oliveira P.J., Moreno A.J., Palmeira C.M. Protective effect of carvedilol on chenodeoxycholate induction of the permeability transition pore. Biochem. Pharmacol. 61:2001b;1449-1454
69. Rolo A.P., Oliveira P.J., Seica R., Santos M.S., Moreno A.J., Palmeira C.M. Improved efficiency of hepatic mitochondrial function in rats with cholestasis induced by an acute dose of α-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 182:2002a;20-26
70. Rolo A.P., Oliveira P.J., Seica R., Santos M.S., Moreno A.J., Palmeira C.M. Disruption of mitochondrial calcium homeostasis following chronic α-naphthylisothiocyanate administration: relevance for cholestasis. J. Invest. Med. 50:2002b;193-200
71. Rolo A.P., Palmeira C.M., Wallace K.B. Interactions of combined bile acids on hepatocyte viability: cytoprotection or sinergism. Toxicol. Lett. 126:2002c;197-203
72. Rolo A.P., Oliveira P.J., Moreno A.J., Palmeira C.M. CDCA induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: protective role of carvedilol. Mitochondrion. 2:2003a;305-311
73. Rolo A.P., Palmeira C.M., Wallace K.B. Mitochondrially mediated synergistic cell killing by bile acids. Biochim. Biophys. Acta. 1637:2003b;127-132
74. Rolo A.P., Palmeira C.M., Holy J.M., Wallace K.B. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol. Sci. 79:2004;196-204
75. Russell D.W., Setchell K.D.R. Bile acid biosynthesis. Biochemistry. 31:1992;4737-4749
76. Rust C., Karnitz L.M., Paya C.V., Moscat J., Simari R.D., Gores G.J. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 275:2000;20210-20216
77. Sarbur C., Kuhajada K., Keveresan S. Evaluation of the lipophilicity of the bile acids and their derivatives by thin-layer chromatography and principal component analysis. J. Chromatogr. A. 917:2001;361-366
78. Scholmerich J., Becher M.S., Schmidt K., Schubert R., Kremer B., Feldhaus S., Gerok W. Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties - studies on isolated hepatocytes and lipid membrane vesicles. Hepatology. 4:1984;661-666
79. Schroder O., Rathner W., Caspary W.F., Stein J. Bile acid-induced increase of rat colonic apical membrane fluidity and proton permeability. Z. Gastroenterol. 34:1996;365-370
80. Shivaram K.N., Winklhofer-Roob B.M., Straka M.S., Devereaux M.W., Everson G., Mierau G.W., Sokol R.J. The effect of idebenone, a coenzyme Q analogue, on hydrophobic bile acid toxicity to isolated rat hepatocytes and hepatic mitochondria. Free Rad. Biol. Med. 25:1998;480-492
81. Sodeman T., Bronk S.F., Roberts P.J., Miyoshi H., Gores G.J. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am. J. Physiol. 278:2000;G992-G999
82. Sokol R.J., Devereaux M., Khandwala R.A. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J. Lipid Res. 32:1991;1349-1357
83. Sokol R.J., Winklhofer-Roob B.M., Devereaux M.W., McKim J.M. Jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 109:1995;1249-1256
84. Sokol R.J., McKim J.M. Jr., Goff M.C., Ruyle S.Z., Devereaux M.W., Han D., Packer L., Everson G. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology. 114:1998;164-174
85. Solá S., Brito M.A., Brites D., Moura J.J., Rodrigues C.M. Membrane structural changes support the involvement of mitochondria in the bile salt-induced apoptosis of rat hepatocytes. Clin. Sci. 103:2002;475-485
86. Spivey J.R., Bronk S.F., Gores G.J. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. J. Clin. Invest. 92:1993;17-24
87. Strupp W., Weindinger G., Scheller C., Ehret R., Ohnimus H., Girschick H., Tas P., Flory E., Heinkelein M., Jassoy C. Treatment of cells with detergents activates caspases and induces apoptotic cell death. J. Membr. Biol. 175:2000;181-189
88. Tanaka M., Nakura H., Tateishi T., Watanabe M., Nakaya S., Kumai T., Kobayashi S. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury. J. Hepatol. 31:1999;263-270
89. Trauner M., Meier P.J., Boyer J.L. Molecular regulation of hepatocellular transport systems in cholestasis. J. Hepatol. 31:1998;165-178
90. van Hoogstraten H.J., Hansen B.E., van Buuren H.R., ten Kate F.J., van Berge-Henegouwen G.P., Schalm S.W. Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group. J. Hepatol. 31:1999;256-262
91. Yerushalmi B., Dahl R., Devereaux M.W., Gumpricht E., Sokol R.J. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology. 33:2001;616-626
92. Yue T.-L., McKenna P.J., Lysko P.J., Gu J.L., Lysco K.A., Ruffolo R.R., Feuerstein G.Z. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur. J. Pharmacol. 251:1994;237-243
93. Zhao D.L., Hirst B.H. Bile salt-induced increases in duodenal brush-border membrane proton permeability, fluidity, and fragility. Dig. Dis. Sci. 35:1990;589-595